PNEUMOSTEM

BIOLOGICAL4 trials

Conditions

Bronchopulmonary DysplasiaCell TransplantationMesenchymal Stromal CellsPremature Birth of NewbornRespiratory Tract InfectionsSevere Bronchopulmonary Dysplasia

Phase 1

Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage

CompletedNCT02274428

Samsung Medical CenterMesenchymal Stromal Cells

Start: 2014-10-31End: 2016-12-31Updated: 2017-04-19

Phase 2

Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)

Active, not recruitingNCT02890953

Samsung Medical CenterCell Transplantation

Start: 2017-03-28End: 2025-12-31Target: 22Updated: 2025-04-13

PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants

CompletedNCT03392467

Medipost Co Ltd.Severe Bronchopulmonary Dysplasia

Start: 2018-08-13End: 2024-10-18Updated: 2025-01-24

Unknown Phase

Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study

CompletedNCT02023788

Medipost Co Ltd.Bronchopulmonary Dysplasia, Premature Birth of Newborn, Respiratory Tract Infections

Start: 2014-04-30End: 2016-10-31Updated: 2018-09-04

Related Papers

Mesenchymal stromal cells for periventricular hemorrhagic infarction in extremely preterm infants: a double-blinded randomized controlled phase IIa clinical trial

Stem Cell Research & Therapy2026-08-24

Stem Cells for Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Controlled Phase II Trial